Featured Articles and Interviews
Aug 28, 2025
How to Invest in Gene Stocks and ETFs
Aug 12, 2025
5 Biggest Pharmaceutical ETFs in 2025
Jul 24, 2025
Biotech and Pharma Market Update: Q2 2025 in Review
More Featured Articles and Inverviews
Press Releases
More Press Releases
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.